Essent | 8-K: FY2026 Q2 Revenue: USD 362.69 M

Revenue: As of FY2026 Q2, the actual value is USD 362.69 M.

EPS: As of FY2026 Q2, the actual value is USD 2.08, beating the estimate of USD 1.7434.

EBIT: As of FY2026 Q2, the actual value is USD 238.47 M.

Overall Financial Performance (Consolidated)

Quarterly Results (Three Months Ended June 30, 2026 vs. June 30, 2025)

• Provision for Losses and LAE: $48.961 million, increased from $17.055 million in the prior year period.
• Total Losses and Expenses: $132.367 million, increased from $87.968 million.
• Income Before Income Taxes: $230.319 million, decreased from $231.175 million.

Year-to-Date Results (Six Months Ended June 30, 2026 vs. June 30, 2025)

• Provision for Losses and LAE: $97.177 million, increased from $48.342 million.
• Total Losses and Expenses: $261.714 million, increased from $198.527 million.
• Income Before Income Taxes: $437.044 million, decreased from $438.174 million.

Balance Sheet (As of June 30, 2026 vs. December 31, 2025)

• Total Assets: $7,591.882 million, increased from $7,441.003 million.
• Total Investments: $6,480.547 million, decreased from $6,486.598 million.
• Cash: $74.333 million, decreased from $123.049 million.
• Reserve for Losses and LAE: $518.799 million, increased from $446.822 million.
• Total Liabilities: $1,928.481 million, increased from $1,684.276 million.
• Total Stockholders’ Equity: $5,663.401 million, decreased from $5,756.727 million.

Operational Metrics

Mortgage Insurance Business

• New Insurance Written (NIW): $14.1 billion for Q2 2026, compared to $11.1 billion in Q1 2026 and $12.5 billion in Q2 2025.
• Insurance in Force: $249.7 billion as of June 30, 2026, compared to $247.9 billion as of March 31, 2026 and $246.8 billion as of June 30, 2025.
• Loss Ratio (H1 2026): 15.5% for Mortgage Insurance, compared to 10.5% for H1 2025.
• Expense Ratio (H1 2026): 16.1% for Mortgage Insurance, compared to 17.0% for H1 2025.
• Combined Ratio (H1 2026): 31.6% for Mortgage Insurance, compared to 27.5% for H1 2025.
• Loans in Default: 20,278 at June 30, 2026, compared to 20,332 at March 31, 2026 and 17,255 at June 30, 2025.
• Percentage of Loans in Default: 2.53% at June 30, 2026, compared to 2.54% at March 31, 2026 and 2.12% at June 30, 2025.
• Cure Rate: 23% for Q2 2026, compared to 65% for Q1 2026 and 87% for Q2 2025.
• Average Amount Paid Per Claim: $55 thousand for Q2 2026, compared to $57 thousand for Q1 2026 and $42 thousand for Q2 2025.
• PMIERs Excess Available Assets: $1,506.170 million at June 30, 2026, compared to $1,551.417 million at March 31, 2026 and $1,579.051 million at June 30, 2025.
• PMIERs Sufficiency Ratio: 172% at June 30, 2026, compared to 174% at March 31, 2026 and 176% at June 30, 2025.

Reinsurance Segment

• Net Premiums Written (H1 2026): $248.8 million, compared to $30.6 million in H1 2025.
• Loss Ratio (H1 2026): 39.3%, significantly increased from 0.1% for H1 2025.
• Expense Ratio (H1 2026): 35.3%, increased from 18.0% for H1 2025.
• Combined Ratio (H1 2026): 74.6%, significantly increased from 18.1% for H1 2025.
• Reinsured Risk in Force: $2,051.720 million at June 30, 2026, decreased from $2,290.008 million at June 30, 2025.

Other Key Metrics

• Book Value Per Share: $63.01 as of June 30, 2026, compared to $56.98 as of June 30, 2025.
• 12-Month Growth in Book Value Per Share: 10.6% for the period ended June 30, 2026.
• Book Value Per Share Inclusive of Common Dividends: $64.33 as of June 30, 2026.
• 12-Month Growth in Book Value Per Share Inclusive of Common Dividends: 12.9% for the period ended June 30, 2026.
• Share Repurchases: Essent Group Ltd. repurchased 5.8 million common shares for $348 million year-to-date through July 31, 2026.
• Quarterly Cash Dividend: Essent Group Ltd. declared a quarterly cash dividend of $0.35 per common share, payable on September 10, 2026.
• Return on Average Equity (Annualized): 13.4% for Q2 2026, compared to 13.8% for Q2 2025.

Outlook / Guidance

The report includes general forward-looking statements about potential risks and uncertainties that could impact actual results. These risks include changes in Government-Sponsored Enterprises (GSEs), competitive pressures, and evolving economic conditions. However, the report does not provide specific financial guidance or quantitative outlook for future periods.